Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Theoretical basis for stabilizing messenger RNA through secondary structure design
Hannah K. Wayment-Steele, Do Soon Kim, Christian A. Choe, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 18, pp. 10604-10617
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Addressing the Cold Reality of mRNA Vaccine Stability
Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 3, pp. 997-1001
Open Access | Times Cited: 400
The dawn of mRNA vaccines: The COVID-19 case
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 385
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
Mohammad N. Uddin, Monzurul Amin Roni
Vaccines (2021) Vol. 9, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 239
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics
Kathrin Leppek, Gun Woo Byeon, Wipapat Kladwang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 204
Algorithm for optimized mRNA design improves stability and immunogenicity
He Zhang, Liang Zhang, Ang Lin, et al.
Nature (2023) Vol. 621, Iss. 7978, pp. 396-403
Open Access | Times Cited: 181
Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
Sun Chang Kim, Simranjeet Singh Sekhon, Woo‐Ri Shin, et al.
Molecular & Cellular Toxicology (2021) Vol. 18, Iss. 1, pp. 1-8
Open Access | Times Cited: 154
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 101
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 73
Research Advances on the Stability of mRNA Vaccines
Feiran Cheng, Yi‐Ping Wang, Yu Bai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 668-668
Open Access | Times Cited: 59
Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 18
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
Lei Yang, Liming Gong, Ping Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2682-2682
Open Access | Times Cited: 62
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 241-253
Open Access | Times Cited: 60
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Ting Le, Chao Sun, Jitao Chang, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 401-401
Open Access | Times Cited: 56
Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach
Bao-Han Ly, Simon Daniel, Shekinah K. V. Soriano, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 6, pp. 1892-1905
Open Access | Times Cited: 55
An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, et al.
Biomaterials (2022) Vol. 286, pp. 121570-121570
Open Access | Times Cited: 49
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments
Niaz Mahmud, Muzahidul I. Anik, M. Khalid Hossain, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 2431-2460
Closed Access | Times Cited: 45
A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines
Marek Kloczewiak, Jessica M. Banks, Lin Jin, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 2022-2031
Open Access | Times Cited: 45
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
Zoltán Kis
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 430-430
Open Access | Times Cited: 40
SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination
José Alfredo Samaniego Castruita, Uffe Vest Schneider, Sarah Mollerup, et al.
Apmis (2023) Vol. 131, Iss. 3, pp. 128-132
Open Access | Times Cited: 35
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Diana D. Kang, Haoyuan Li, Yizhou Dong
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114961-114961
Open Access | Times Cited: 34
Reversible 2′-OH acylation enhances RNA stability
Linglan Fang, Lu Xiao, Yong Woong Jun, et al.
Nature Chemistry (2023) Vol. 15, Iss. 9, pp. 1296-1305
Open Access | Times Cited: 30
An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109934-109934
Open Access | Times Cited: 27
Mutation signature filtering enables high-fidelity RNA structure probing at all four nucleobases with DMS
David Mitchell, Jennifer A. Cotter, Irfana Saleem, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 16, pp. 8744-8757
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top